US 8470296
Intracorporeal medicaments for high energy phototherapeutic treatment of disease
granted A61KA61K31/352
Quick answer
US patent 8470296 (Intracorporeal medicaments for high energy phototherapeutic treatment of disease) held by Provectus Pharmatech, Inc. expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Provectus Pharmatech, Inc.
- Grant date
- Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/352